Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$30.27 USD
+0.19 (0.63%)
Updated May 2, 2024 04:00 PM ET
After-Market: $30.27 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: AMC |
3/2024 | $0.39 | 0.00% |
Earnings Summary
For their last quarter, Supernus Pharmaceuticals (SUPN) reported earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.41 per share. This reflects a negative earnings surprise of 95.12%. Look out for SUPN's next earnings release on May 08, 2024. For the next earning release, we expect the company to report earnings of $0.39 per share, reflecting a year-over-year increase of 34.48%.
Earnings History
Price & Consensus
Zacks News for SUPN
Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
SUPN: What are Zacks experts saying now?
Zacks Private Portfolio Services